DuPont de Nemours, Inc. DD Healthcare Technologies — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DuPont de Nemours, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: DuPont de Nemours, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about DuPont de Nemours, Inc.'s healthcare technologies — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is DuPont de Nemours, Inc.'s healthcare technologies — net sales?
- DuPont de Nemours, Inc. (DD) reported healthcare technologies — net sales of $467M in Q1 2026.
- How has DuPont de Nemours, Inc.'s healthcare technologies — net sales changed year-over-year?
- DuPont de Nemours, Inc.'s healthcare technologies — net sales increased by 11.5% year-over-year, from $419M to $467M.
- What does healthcare technologies — net sales mean?
- This metric represents the total revenue generated from the sale of goods and services within the healthcare technologies business segment. It encompasses specialized products, materials, and solutions provided to the medical, pharmaceutical, and healthcare industries. This figure reflects the segment's market demand and its ability to monetize its portfolio of advanced chemical and material science innovations.